Malaria expert Brian Greenwood had once resigned himself to the possibility that a successful vaccine for the disease might not become available in his lifetime. Now, at 86 years old, the moment he’s spent four decades working toward has arrived. “It’s been a long journey with many ups and downs,” says Greenwood, still an active […]
Read MoreThough homegrown malaria recently flared in the US, “there’s no high-income market for this product,” says Aurélia Nguyen, the chief program officer of Gavi, the Vaccine Alliance, which has made an initial commitment of $155 million to bring the new formulas to market and is beginning work on what it calls an African vaccine manufacturer […]
Read MoreAt least four people in Florida and one in Texas have been diagnosed with malaria that they must have caught near where they live—because, according to health officials, none of them traveled outside the US or their own states. The very unusual discovery has left infectious disease specialists wondering: Who else might be ill, and […]
Read MoreThough Bd swept through Central America from the 1980s to the 2000s, the analysis that demonstrated its effect on human health could be accomplished only recently, says Michael Springborn, the paper’s lead author and a professor and environmental and resource economist at UC Davis. “The data existed, but it wasn’t easily obtainable,” he says. Over […]
Read More
